Navya Biologicals Pvt. Ltd. (NBPL), aims to re-imagine bioprocesses to make accessible high quality, low cost biologic therapies to the global population with a pool of talented scientists from world-class institutes across the globe. We are focused on developing high quality bio pharmaceuticals. The current focus is on development and commercialization of products in Oncology (Cancer), Auto-Immune Disease, Ophthalmology and Nephrology.

The NBPL’s strengths have been its ability to identify innovative and appropriate technologies across the world and to ensure that they are successfully adopted to meet our vision by our integrated R&D team having end-to-end expertise for biosimilar products development along with dedicated Quality Assurance team working closely with R&D to ensure highest standards for documentation and regulatory submissions.